Lineage Cell Therapeutics (LCTX) Return on Capital Employed Growth (1y) (2012 - 2026)
Lineage Cell Therapeutics (LCTX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | -3,457.00 |
| 10 | Lineage Cell Therapeutics | 257.28 Mn | 194.56 Mn | 1.73 Mn | -1,519.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,519.00 |
| Dec 31, 2025 | -1,718.00 |
| Sep 30, 2025 | -1,704.00 |
| Jun 30, 2025 | -1,060.00 |
| Mar 31, 2025 | 672.00 |
| Dec 31, 2024 | 526.00 |
| Sep 30, 2024 | 40.00 |
| Jun 30, 2024 | -389.00 |
| Mar 31, 2024 | -568.00 |
| Dec 31, 2023 | -811.00 |
| Sep 30, 2023 | 1,294.00 |
| Jun 30, 2023 | 1,527.00 |
| Mar 31, 2023 | 1,349.00 |
| Dec 31, 2022 | 2,576.00 |
| Sep 30, 2022 | -1,820.00 |
| Jun 30, 2022 | -1,824.00 |
| Mar 31, 2022 | -1,257.00 |
| Dec 31, 2021 | -1,947.00 |
| Sep 30, 2021 | 586.00 |
| Jun 30, 2021 | 552.00 |